Community Fundraising Wrap Up Jan-Mar 2021
15 April 2021
It's been a while since we last recognised the generous support of our amazing community fundraisers. The easing of COVID-19 restrictions has seen the return of some of our annual events and the start of the running event season. We are extremely grateful to our community fundraisers who continue to support us in these challenging times so we can move closer to our goal of zero deaths from melanoma.
Our first annual event to return this year was the Erik Mather 2, 4, 6 Swim hosted by the Balmoral Beach Club. A huge thank you to the entire club and Monika Mather for raising over $50,000 to support MIA’s Erik Mather PhD Scholarship program. Despite the rain, the conditions were perfect for ocean swimming and even MIA’s CEO Matthew Browne, Medical Directors Prof Georgina Long AO and Prof Richard Scolyer, and Prof Anne Cust donned their wetsuits and joined the swim. Congrats to all involved for another successful event!
Last year a much-loved member of the Cockburn Cricket Club Ladies Team was diagnosed with Stage IV melanoma. So, on 20 February the Cockburn Cricket Club held a Ladies' Day with plenty of food, games, and prizes, plus guest speakers - Andrew Kamphaug, from MIA WA and Paige McNeil from the MIA Speakers’ Hub. Thank you to Amanda Rowe and all those who attended to help raise $6,750 for vital life-saving research.
A massive thanks to 'Team Just Keep Swimming' (shown at top from left to right: Tania, Tammie, Anna and Kiara), and solo swimmer Flavia (shown at bottom, second from left, with her support crew) for their incredible efforts during the South32 Rottnest Channel Swim in March. Despite gruelling conditions in the water, the swimmers raised a combined total of $8,510, what an incredible result!
On 28 March, RunWest in Western Sydney was the first event to kick off the running season. We had 26 people representing Team Melanoma who collectively raised $1,140! A big thanks to all who participated and a special shout out to our top three fundraisers: Tara Kairouz, Lisa Duclos,and Sharon Hewitt.
Deb Guion sadly lost her husband, Omri Godijn, to melanoma shortly after his 46th birthday earlier this year. Deb believes MIA's research was instrumental in extending Omri's life by at least 18 months. Deb chose to set up a fundraising page in memory of Omri to support MIA's ongoing research in the hope of changing the outcomes for all future melanoma patients. An enormous thank you to Deb and all your friends and family for raising over $14,000.
We are so thankful for the generous support from all our community fundraisers. Your efforts don't go unnoticed and everything you do helps us move closer to our goal of zero deaths from melanoma, a goal our Co-Medical Directors believe we can reach this decade.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.
Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.
CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series.
MIA's 'Stop the Spread' campaign has been shortlisted in the 2016 Cannes Lions International Festival of Creativity.
MIA's doctors are converging on Chicago this week along with 40,000 delegates from around the globe at the biggest oncology conference in the world.
We are pleased to announce a recent expansion to the dermatology services at Melanoma Institute Australia.
This International Clinical Trials Day we reflect on the importance of clinical trials and the people who dedicate their lives to helping melanoma patients today and in the future.
MIA has launched its first eBook Melanoma Essentials – A Concise Guide, a resource for GPs and other medical, nursing and allied professionals to help them effectively diagnose and manage cases.
Dr Scot Ebbinghaus chats to us about an exciting clinical trial at MIA and where melanoma treatment is headed in the future.
A new melanoma treatment has been listed on the PBS today, giving another option for advanced melanoma patients.